πŸ‡ΊπŸ‡Έ FDA
Patent

US 10556897

Protein kinase inhibitors

granted A61KA61K31/506A61K45/06

Quick answer

US patent 10556897 (Protein kinase inhibitors) held by Princeton Drug Discovery, Inc expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Princeton Drug Discovery, Inc
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/506, A61K45/06, A61P, A61P25/28